Complement receptor type two (CR2,CR21)A target for influencing the humoral immune response and antigen-trapping

被引：0
|
作者：
Wolfgang M. Prodinger
机构：
[1] University of Innsbruck,Institut für Hygiene
来源：
Immunologic Research | 1999年 / 20卷
关键词：
Complement; C3; Receptor; CD21; Structure; Immunity; EBV; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cellular receptors for complement C3 fragments deposited on antigens are important bricks in the wall defending against microbial pathogens. The part of complement receptor type 2 (CR2; CD21) deals with enhancing humoral immune responses and with long-term trapping of C3d-coated antigen by follicular dendritic cells. CR2 is also pivotal for Epstein-Barr virus (EBV) infection. Here, the current understanding, how CR2 interacts with its ligands C3d, EBV, and CD23 is summarized. The potential to target CR2 for clinical therapy or immunization purposes are discussed.
引用
收藏
页码：187 / 194
页数：7
相关论文
共 50 条
  • [31] Specific phenotypes induced by deficiency of complement receptors type 1 (CR1/CD35) and type 2 (CR2/CD21) in murine SLE
    Boackle, SA
    Culhane, KK
    Brown, JM
    Haas, M
    Bao, LH
    Quigg, RJ
    Holers, VM
    FASEB JOURNAL, 2002, 16 (05): : A1217 - A1218
  • [32] C3 regulates expression of human complement receptor 2 (CR2, CD21) on mouse B cells
    Marchbank, KJ
    Kulik, L
    Birrell, L
    Haluzcszak, C
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 272 - 272
  • [33] Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis
    Masilamani, M
    von Kempis, J
    Illges, H
    RHEUMATOLOGY, 2004, 43 (02) : 186 - 190
  • [34] Mice with genetic deficiency for complement receptor type 2 (CR2) show neuroprotection after experimental closed head injury
    Neher, Miriam
    Rich, Megan
    Keene, Chesleigh
    Weckbach, Sebastian
    Bolden, Ashley
    Losacco, Justin
    Holers, Michael
    Stahel, Philip
    BRAIN INJURY, 2014, 28 (5-6) : 564 - 564
  • [35] MICE WITH GENETIC DEFICIENCY FOR COMPLEMENT RECEPTOR TYPE 2 (CR2) SHOW NEUROPROTECTION AFTER EXPERIMENTAL CLOSED HEAD INJURY
    Keene, Chesleigh
    Neher, Miriam
    Rich, Megan
    Weckbach, Sebastian
    Bolden, Ashley
    Losacco, Justin
    Holers, V. Michael
    Stahel, Philip F.
    JOURNAL OF NEUROTRAUMA, 2013, 30 (15) : A150 - A150
  • [36] High levels of human complement receptor 2 (CR2, CD21) expression in Cr2-/- mice results in a marked reduction in peripheral B cell numbers
    Marchbank, KJ
    Gibson, M
    Morgan, BP
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 109 - 109
  • [37] Molecular characterization of complement receptor 2 (CR2/CD21)-mediated B cell activation triggered by a sub-threshold dose of C3dg-conjugated antigen: CR2 ligation can break tolerance to self antigens
    Lyubchenko, TA
    Dal Porto, JM
    Cambier, JC
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 270 - 271
  • [38] Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350
    Young, Kendra A.
    Herbert, Andrew P.
    Barlow, Paul N.
    Holers, V. Michael
    Hannan, Jonathan P.
    JOURNAL OF VIROLOGY, 2008, 82 (22) : 11217 - 11227
  • [39] An intronic silencer regulates B lymphocyte cell and stage specific expression of the human complement receptor type 2 (CR2,CD21) gene.
    Makar, KW
    Pham, CT
    Dehoff, M
    OConnor, S
    Jacobi, S
    Holers, VM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 980 - 980
  • [40] Development of in vivo models for studying the transcriptional regulation of human complement receptor 2 (CR2/CD21): importance of chromatin accessibility
    Cruikshank, MN
    Goldie, LC
    Holers, VM
    Abraham, LJ
    Ulgiati, D
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 224 - 224
12345